Seasoned financial advisor, investment manager and corporate director Dr Nigel Finch is back in the radio booth for another instalment of The StockDoc Podcast.
In this episode, the good doctor sits down with Michelle Gallaher, CEO of Opyl (ASX:OPL).
Opyl is an ASX-listed company that provides biopharma and health organisations access to emerging AI-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery.
Click below to hear more about the company’s ‘new generation’ offering.